Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease
Claudio Liguori, Agostino Chiaravalloti, Giuseppe Sancesario, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2016) Vol. 43, Iss. 11, pp. 2040-2049
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer’s Disease Biomarkers Changes
Claudio Liguori, Nicola Biagio Mercuri, Francesca Izzi, et al.
SLEEP (2017)
Open Access | Times Cited: 186
The biological pathways of Alzheimer disease: a review
Marco Calabrò, Carmela Rinaldi, Giuseppe Santoro, et al.
AIMS neuroscience (2020) Vol. 8, Iss. 1, pp. 86-132
Open Access | Times Cited: 180
Lactate Metabolism, Signaling, and Function in Brain Development, Synaptic Plasticity, Angiogenesis, and Neurodegenerative Diseases
Anika Wu, Daehoon Lee, Wen‐Cheng Xiong
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13398-13398
Open Access | Times Cited: 41
Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease
Somang Kang, Yong‐ho Lee, Jong Eun Lee
Yonsei Medical Journal (2017) Vol. 58, Iss. 3, pp. 479-479
Open Access | Times Cited: 121
Lactate Deficit in an Alzheimer Disease Mouse Model: The Relationship With Neuronal Damage
Mao Zhang, Xiaofang Cheng, Ruozhi Dang, et al.
Journal of Neuropathology & Experimental Neurology (2018) Vol. 77, Iss. 12, pp. 1163-1176
Open Access | Times Cited: 88
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment
Lorenzo Gaetani, Federico Paolini Paoletti, G. Bellomo, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 12, pp. 1023-1037
Closed Access | Times Cited: 71
The Microbiota–Gut–Brain Axis in Alzheimer’s Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions
Emily R. Murray, Mylon Kemp, Tanya T. Nguyen
Archives of Clinical Neuropsychology (2022) Vol. 37, Iss. 3, pp. 595-607
Open Access | Times Cited: 48
Lactate metabolism in neurodegenerative diseases
Chaoguang Yang, Rui‐Yuan Pan, Fangxia Guan, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 1, pp. 69-74
Open Access | Times Cited: 34
Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment
Hideo Hagihara, Hirotaka Shoji, Satoko Hattori, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 11
What Is the Role of Lactate in Brain Metabolism, Plasticity, and Neurodegeneration?
Eduardo E. Benarroch
Neurology (2024) Vol. 102, Iss. 9
Closed Access | Times Cited: 9
Global Metabolic Shifts in Age and Alzheimer’s Disease Mouse Brains Pivot at NAD+/NADH Redox Sites
Yue Dong, Gregory J. Brewer
Journal of Alzheimer s Disease (2019) Vol. 71, Iss. 1, pp. 119-140
Open Access | Times Cited: 74
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 511-531
Open Access | Times Cited: 54
Metabolic dysfunction in OSA: Is there something new under the sun?
Isaac Almendros, Özen K. Başoğlu, Sílvia V. Conde, et al.
Journal of Sleep Research (2021) Vol. 31, Iss. 1
Open Access | Times Cited: 46
Friend or foe: Lactate in neurodegenerative diseases
Mingyu Wang, Yang Zhou, Wenlian Li, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102452-102452
Closed Access | Times Cited: 6
Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers
Roni Manyevitch, Matthew Protas, Sean Scarpiello, et al.
Current Alzheimer Research (2018) Vol. 15, Iss. 2, pp. 164-181
Open Access | Times Cited: 55
Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development
Shiveena Bhatia, Rishi Rawal, Pratibha Sharma, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 4, pp. 675-692
Open Access | Times Cited: 34
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment
Mariana Fernandes, Luisa Mari, Agostino Chiaravalloti, et al.
Journal of Neurology (2022) Vol. 269, Iss. 10, pp. 5356-5367
Open Access | Times Cited: 23
L-Lactate Administration Improved Synaptic Plasticity and Cognition in Early 3xTg-AD Mice
Yaxin Wang, Jinfeng Zhao, Li Zhao
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1486-1486
Open Access
Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease
Guannan Zhu, Hong Zhang, Ruoxi Xie, et al.
Advanced Healthcare Materials (2025)
Closed Access
Lactylation in CNS disorders: mechanisms, cellular function, and disease relevance
Jiaxin Tian, Tongyu Zhang, Ruidan Zhang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease
Claudio Liguori, Agostino Chiaravalloti, Marzia Nuccetelli, et al.
Journal of Neurology (2017) Vol. 264, Iss. 11, pp. 2215-2223
Closed Access | Times Cited: 43
Metabolism navigates neural cell fate in development, aging and neurodegeneration
Larissa Traxler, Jessica Lagerwall, Sophie Eichhorner, et al.
Disease Models & Mechanisms (2021) Vol. 14, Iss. 8
Open Access | Times Cited: 29
Several dementia subtypes and mild cognitive impairment share brain reduction of neurotransmitter precursor amino acids, impaired energy metabolism, and lipid hyperoxidation
Roberto Aquilani, Matteo Cotta Ramusino, Roberto Maestri, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 11
Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
Stefan L.C. Geijselaers, Pauline Aalten, Inez H.G.B. Ramakers, et al.
Journal of Alzheimer s Disease (2017) Vol. 61, Iss. 1, pp. 309-320
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top